Deferoxamine cardioplegia reduces superoxide radical production in human myocardium
- 31 January 1995
- journal article
- clinical trial
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 59 (1) , 169-172
- https://doi.org/10.1016/0003-4975(94)00726-n
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- A promising approach for improving the recovery of heart transplantsThe Journal of Thoracic and Cardiovascular Surgery, 1990
- Protection against tissue damage in vivo by desferrioxamine: What is its mechanism of action?Free Radical Biology & Medicine, 1989
- Free radicals and myocardial ischemia: Overview and outlookFree Radical Biology & Medicine, 1988
- Oxygen free radicals and iron in relation to biology and medicine: Some problems and conceptsArchives of Biochemistry and Biophysics, 1986
- Increased production of peroxidation products associated with cardiac operationsThe Journal of Thoracic and Cardiovascular Surgery, 1986
- The oxygen free radical system: Potential mediator of myocardial injuryJournal of the American College of Cardiology, 1985
- Molecular oxygen: Friend and foe: The role of the oxygen free radical system in the calcium paradox, the oxygen paradox and ischemia/reperfusion injuryJournal of Molecular and Cellular Cardiology, 1984
- Desferrioxamine: a scavenger of superoxide radicals?Biochemical Pharmacology, 1984
- Inhibition of the iron-catalysed formation of hydroxyl radicals from superoxide and of lipid peroxidation by desferrioxamineBiochemical Journal, 1979
- [30] Microsomal lipid peroxidationPublished by Elsevier ,1978